Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients-Reference-Cited by-同舟云学术

Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients

Published:2017-06 Issue: Volume:59 Page:118-123
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Castón Juan J.,Lacort-Peralta Isabel,Martín-Dávila Pilar,Loeches Belén,Tabares Salvador,Temkin Liz,Torre-Cisneros Julián,Paño-Pardo José R.

Funder

Hospital Universitario Reina Sofía-IMIBIC

Hospital Universitario La Paz-IDIPAZ

Tel Aviv Sourasky Medical Center

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference20 articles.

1. Prescribing information;Acycaz (Ceftazidime-avibactam),2016

2. Center for Disease Control and Prevention - Healthcare-associated Infections (HAIs): CRE Definition. https://www.cdc.gov/hai/organisms/cre/definition.html.

3. In vitro susceptibility to ceftazidime-avibactam of carbapenem-nonsusceptible Enterobacteriaceae isolates collected during the INFORM global surveillance study (2012-2014);de Jonge;Antimicrob Agents Chemother,2016

4. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America;Freifeld;Clin Infect Dis,2011

5. Assesment of the in vitro activity of ceftazidime-avibactam against multidrug-resistant Klebsiella spp. collected in the INFORM global surveillance study, 2012 to 2014;Hackel;Antimicrob Agents Chemother,2016

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rectal culture could predict carbapenem-resistant organism bloodstream infection and reduce the mortality in haematological patients: A retrospective cohort study;Journal of Global Antimicrobial Resistance;2024-03

2. Carbapenem-resistant Klebsiella pneumoniae bloodstream infections in haematological malignances and hematopoietic stem cell transplantation: Clinical impact of combination therapy in a 10-year Brazilian cohort;PLOS ONE;2024-01-26

3. Ceftazidime-avibactam induced renal disorders: past and present;Frontiers in Pharmacology;2024-01-22

4. Effectiveness and safety of cefotaxime combined with avibactam for treating multidrug-resistant E coli infections: A systematic review and meta-analysis;Medicine;2024-01-19

5. Ceftazidime–Avibactam Improves Outcomes in High-Risk Neutropenic Patients with Klebsiella pneumoniae Carbapenemase-Producing Enterobacterales Bacteremia;Microorganisms;2024-01-18